دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study
Waseem Ahmed, MD,*, Wade Billing, MD,*, Timothy E. Stump, MA,†Thomas Strobel, MD,‡, Sashidhar Sagi, MD,* Monika Fischer, MD,* and Mathew Bohm, DO
doi : 10.1093/ibd/izac218
Inflammatory Bowel Diseases, Volume 29, Issue 9, September 2023, Pages 1355–1361
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota
Claudia Herrera-deGuise, MD,*,†, Encarna Varela, MD,*,†Guillaume Sarrabayrouse, PhD,*,†,‡ Marta Pozuelo del R?o, PhD,*,†Virginia Robles Alonso, MD,*,†Natalia Borruel Sainz, MD,*,†Francesc Casellas, MD,*,†Luis Fernando Mayorga, MD,*,†Chaysavanh Manichanh, PhD,*,†Fernando Azpiroz Vidaur, MD,*,†and Francisco Guarner, MD
doi : 10.1093/ibd/izad058
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
Luc Biedermann, MD,* Marla C. Dubinsky, MD,†Séverine Vermeire, MD,‡ Marc Fellmann, PhD, §, Sean Gardiner, MD,¶ Peter Hur, PharmD,¶ Rajiv Mundayat, MSc,¶ Julian Panés, MD,? and David T. Rubin, MD**
doi : 10.1093/ibd/izac222
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response
Marialaura Cuomo, MD,* Alessandra Carobbio, MSc,†Marina Aloi, MD, PhD, ¶ Patrizia Alvisi, MD, PhD,? Claudia Banzato, MD,** Luca Bosa, MD,††Matteo Bramuzzo, MD,‡‡, Angelo Campanozzi, MD,§§ Giulia Catassi, MD,¶ Lorenzo D’Antiga, MD,‡ Monica Di Paola, MD,¶¶ Enrico Felici, MD,?? Maria Teresa Fioretti, MD,*** Simona Gatti, MD, PhD, †††Francesco Graziano, MD,‡‡‡, Sara Lega, MD,‡‡ Paolo Lionetti, MD, PhD, §§, Antonio Marseglia, MD,§§§ Massimo Martinelli, MD, PhD,¶¶ Francesca Musto, MD,§ Naire Sansotta, MD, ‡ Luca Scarallo, MD,§§ Giovanna Zuin, MD,§ and Lorenzo Norsa, MD, PhD
doi : 10.1093/ibd/izac215
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn’s Disease
Emily C.L. Wong, BHSc,*,†Parambir S. Dulai, MD, ‡, John K. Marshall, MD, MSc, FRCPC,*,†Vipul Jairath, MD, PhD, § Walter Reinisch, MD, PhD, ¶ and Neeraj Narula, MD, MPH, FRCPC
doi : 10.1093/ibd/izac231
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease
Takahiro Shimoyama, MD,* Takayuki Yamamoto, MD, PhD,*, Shigeyuki Yoshiyama, MD, PhD,* Ryutaro Nishikawa, MD,* and Satoru Umegae, MD, PhD
doi : 10.1093/ibd/izac230
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study
Marietta Iacucci, PhD,*,†,‡, Louisa Jeffery, PhD,†,‡,a Animesh Acharjee, PhD, §,¶,a, Enrico Grisan, PhD,?,** Andrea Buda, PhD, ††Olga M. Nardone, PhD, ‡, Samuel C.L. Smith, PhD,‡ Nunzia Labarile, MD,‡ Davide Zardo, PhD,†Bella Ungar, PhD,‡ Stuart Hunter, PhD,‡ Ren Mao, PhD,‡‡, Rosanna Cannatelli, MD,‡ Uday N. Shivaji, PhD,†,‡ Tommaso Lorenzo Parigi, MD, ‡, Gary M. Reynolds, PhD, § Georgios V. Gkoutos, PhD,*,‡,§ and Subrata Ghosh, PhD
doi : 10.1093/ibd/izac233
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Julian Panés, MD, PhD,*, Edward V. Loftus Jr, MD,†Peter D. R. Higgins, MD, PhD, MS,‡ James O. Lindsay, PhD, FRCP, § Wen Zhou, MD, PhD,¶ Xuan Yao,¶ Dapo Ilo, MD,¶ Charles Phillips, MD,¶ Jacinda Tran, PharmD,? Yuri, Sanchez Gonzalez PhD, ¶ and Séverine Vermeire, MD, PhD
doi : 10.1093/ibd/izac260
Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning
Gorkem Polat, MSc,*,†,a Haluk Tarik Kani, MD, ‡,a, Ilkay Ergenc, MD,‡,a Yesim Ozen Alahdab, MD, ‡ Alptekin Temizel, PhD,*,†,b and Ozlen Atug, MD
doi : 10.1093/ibd/izac226
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes
An Outtier, MD,*,†, Liese Gijbels,* Maja Noman, MD,* Bram Verstockt, MD, PhD,*,†, Jo?o Sabino, MD, PhD,*,†Séverine Vermeire, MD, PhD,*,†and Marc Ferrante MD, PhD
doi : 10.1093/ibd/izac227
Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis
Liyan Deng, BS,*,# Shasha He, PhD, †,# Ying Li, BS,*,# Rui Ding, BS, ‡ Xiaoling Li, MS, § Nuoqing Guo, BS,* Lianxiang Luo, PhD
doi : 10.1093/ibd/izad050
Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis
Xinhui Yang, MD,*, Jintong Shi, MS,*,†Gaoyang Wang, MS,*,†Huifang Chen, MS,*,†Youqiong Ye, PhD,*,†Jie Zhong, MD,* and Zhengting Wang, MD
doi : 10.1093/ibd/izad060
COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study
Bente Mertz N?rg?rd*,†, Floor Dijkstra Zegers*,†, Jan Nielsen*,†, Torben Knudsen‡,§, and Jens Kjeldsen
doi : 10.1093/ibd/izad070
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Sara Massironi, MD, PhD,*,†, Lorena Pirola, MD,* Giacomo Mulinacci, MD,* Antonio Ciaccio, MD,*,†Chiara Vigan?, MD,* Andrea Palermo, MD,* Alessandra Zilli, MD,‡,§ Pietro Invernizzi, MD, PhD,*,†and Silvio Danese, MD, PhD
doi : 10.1093/ibd/izac189
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases
Duncan Rutherford, MBChB , and Gwo-Tzer Ho, PhD, FRCP
doi : 10.1093/ibd/izad044
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn’s Disease
Kaylie Chen, BS,*, Johnson Chen, MD,†Emily Smith, MD,* Prerna Mathani, MS,* Randy Longman, MD PhD,* Dana Lukin, MD PhD,* Ellen Scherl, MD,* Juliette Gerber, BS,* and Robert Battat, MD CM
doi : 10.1093/ibd/izac236
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States
Shintaro Akiyama, MD, PhD,*,‡,a Nathaniel A. Cohen, MD,*,a Maia Kayal, MD, MS, †,a, Marla C. Dubinsky, MD,†Jean-Frederic Colombel, MD,†, and David T. Rubin, MD
doi : 10.1093/ibd/izad011
How to Minimize Placebo Response and Remission Rates
Mark A. Ainsworth, MD, PhD, DMSc
doi : 10.1093/ibd/izac240
The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn’s Colitis Care e-Health Consumer Platform
Jack McNamara, MBBS,*,†,‡, Susan J. Connor, MBBS, PhD, *,†,‡,§ and Jane M. Andrews, MBBS, PhD
doi : 10.1093/ibd/izad148
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab
Claudia Carpineti, MD,* Cristina Mugheddu, MD,†Marta Cadoni, MD,* Jasmine Anedda, MD,†Laura Atzori, MD,†Massimo C. Fantini, MD,* and Sara Onali, MD
doi : 10.1093/ibd/izad107
Correction to: Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis
doi : 10.1093/ibd/izad101
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts
Eran Zittan, MD,*, Hussein Mahajna, MD,*,†, and NirSalomon
doi : 10.1093/ibd/izad072
Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease
Lauren Loeb, MD,*, Ayan Nasir, MD,* Michael F. Picco, MD, PhD, †Jana G. Hashash, MD, MSc,†, Jami A. Kinnucan, MD, †and Francis A. Farraye, MD, MSc
doi : 10.1093/ibd/izad088
Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis
Xinhui Yang, MD,*, Jintong Shi, MS,*,†Gaoyang Wang, MS,*,†Huifang Chen, MS,*,†Youqiong Ye, PhD,*,†Jie Zhong, MD,* and Zhengting Wang, MD
doi : 10.1093/ibd/izad060
COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study
Bente Mertz N?rg?rd*,†, Floor Dijkstra Zegers*,†, Jan Nielsen*,†, Torben Knudsen‡,§, and Jens Kjeldsen
doi : 10.1093/ibd/izad070
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Sara Massironi, MD, PhD,*,†, Lorena Pirola, MD,* Giacomo Mulinacci, MD,* Antonio Ciaccio, MD,*,†Chiara Vigan?, MD,* Andrea Palermo, MD,* Alessandra Zilli, MD,‡,§ Pietro Invernizzi, MD, PhD,*,†and Silvio Danese, MD, PhD
doi : 10.1093/ibd/izac189
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases
Duncan Rutherford, MBChB , and Gwo-Tzer Ho, PhD, FRCP
doi : 10.1093/ibd/izad044
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn’s Disease
Kaylie Chen, BS,*, Johnson Chen, MD,†Emily Smith, MD,* Prerna Mathani, MS,* Randy Longman, MD PhD,* Dana Lukin, MD PhD,* Ellen Scherl, MD,* Juliette Gerber, BS,* and Robert Battat, MD CM
doi : 10.1093/ibd/izac236
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States
Shintaro Akiyama, MD, PhD,*,‡,a Nathaniel A. Cohen, MD,*,a Maia Kayal, MD, MS, †,a, Marla C. Dubinsky, MD,†Jean-Frederic Colombel, MD,†, and David T. Rubin, MD
doi : 10.1093/ibd/izad011
How to Minimize Placebo Response and Remission Rates
Mark A. Ainsworth, MD, PhD, DMSc
doi : 10.1093/ibd/izac240
The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn’s Colitis Care e-Health Consumer Platform
Jack McNamara, MBBS,*,†,‡, Susan J. Connor, MBBS, PhD, *,†,‡,§ and Jane M. Andrews, MBBS, PhD
doi : 10.1093/ibd/izad148
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab
Claudia Carpineti, MD,* Cristina Mugheddu, MD,†Marta Cadoni, MD,* Jasmine Anedda, MD,†Laura Atzori, MD,†Massimo C. Fantini, MD,* and Sara Onali, MD
doi : 10.1093/ibd/izad107
Correction to: Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis
doi : 10.1093/ibd/izad101
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts
Eran Zittan, MD,*, Hussein Mahajna, MD,*,†, and NirSalomon
doi : 10.1093/ibd/izad072
Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease
Lauren Loeb, MD,*, Ayan Nasir, MD,* Michael F. Picco, MD, PhD, †Jana G. Hashash, MD, MSc,†, Jami A. Kinnucan, MD, †and Francis A. Farraye, MD, MSc
doi : 10.1093/ibd/izad088
